Inflammatory Bowel Disease and the Risk of Prostate Cancer
Inflammatory Bowel Disease and the Risk of Prostate Cancer
复制标题
DOI:
10.1016/j.eururo.2018.11.039
复制
发表时间:
2019-05-01
期刊:
影响因子:
23.4
通讯作者:
Kundu, Shilajit D.
中科院分区:
文献类型:
--
作者:
Burns, Jacob A.;Weiner, Adam B.;Kundu, Shilajit D.
Background: There are limited data examining the risk of prostate cancer (PCa) in patients with inflammatory bowel disease (IBD).Objective: To compare the incidence of PCa between men with and those without IBD.Design, setting, and participants: This was a retrospective, matched-cohort study involving a single academic medical center and conducted from 1996 to 2017. Male patients with IBD (cases = 1033) were randomly matched 1:9 by age and race to men without IBD (controls = 9306). All patients had undergone at least one prostate-specific antigen (PSA) screening test.Outcome measurements and statistical analysis: Kaplan-Meier and multivariable Cox proportional hazard models, stratified by age and race, evaluated the relationship between IBD and the incidence of any PCa and clinically significant PCa (Gleason grade group >= 2). A mixed-effect regression model assessed the association of IBD with PSA level.Results and limitations: PCa incidence at 10 yr was 4.4% among men with IBD and 0.65% among controls (hazard ratio [HR] 4.84 [3.34-7.02] [3.19-6.69], p